A detailed history of Td Asset Management Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Td Asset Management Inc holds 44,140 shares of BNTX stock, worth $5.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,140
Previous 7,590 481.55%
Holding current value
$5.39 Million
Previous $609,000 760.76%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$78.36 - $124.66 $2.86 Million - $4.56 Million
36,550 Added 481.55%
44,140 $5.24 Million
Q2 2024

Aug 02, 2024

BUY
$80.36 - $102.87 $34,956 - $44,748
435 Added 6.08%
7,590 $609,000
Q1 2024

May 08, 2024

BUY
$88.96 - $112.35 $636,508 - $803,864
7,155 New
7,155 $660,000
Q4 2022

Feb 06, 2023

SELL
$118.43 - $186.05 $3.79 Million - $5.96 Million
-32,035 Reduced 38.68%
50,786 $7.63 Million
Q3 2022

Nov 07, 2022

BUY
$127.65 - $183.11 $278,915 - $400,095
2,185 Added 2.71%
82,821 $11.1 Million
Q2 2022

Aug 04, 2022

SELL
$123.25 - $186.24 $2.99 Million - $4.51 Million
-24,223 Reduced 23.1%
80,636 $12 Million
Q1 2022

May 10, 2022

BUY
$126.25 - $231.85 $214,751 - $394,376
1,701 Added 1.65%
104,859 $17.9 Million
Q4 2021

Feb 10, 2022

BUY
$216.64 - $362.52 $5.15 Million - $8.61 Million
23,758 Added 29.92%
103,158 $26.6 Million
Q3 2021

Nov 09, 2021

SELL
$205.93 - $447.23 $13.9 Million - $30.1 Million
-67,355 Reduced 45.9%
79,400 $21.7 Million
Q2 2021

Aug 11, 2021

BUY
$113.32 - $241.49 $2.92 Million - $6.23 Million
25,784 Added 21.31%
146,755 $48.2 Million
Q1 2021

May 14, 2021

BUY
$85.73 - $119.5 $2.84 Million - $3.96 Million
33,106 Added 37.68%
120,971 $13.2 Million
Q4 2020

Feb 16, 2021

BUY
$72.71 - $129.54 $2.12 Million - $3.77 Million
29,100 Added 49.52%
87,865 $7.16 Million
Q3 2020

Nov 10, 2020

BUY
$57.81 - $104.17 $2.48 Million - $4.47 Million
42,865 Added 269.59%
58,765 $4.07 Million
Q2 2020

Aug 13, 2020

BUY
$38.58 - $66.74 $613,422 - $1.06 Million
15,900 New
15,900 $1.06 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.6B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.